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Abstract
Background: There are still a large variety of microorganisms among aquatic animals which have not been
explored for their pharmacological potential. Hence, present study was aimed to isolate and characterize a potent
lactic acid bacterium from fresh water fish sample Zacco koreanus, and to confirm its pharmacological potential.
Methods: Isolation of lactic acid bacteria (LAB) from fresh water fish samples was done using serial dilution
method. Biochemical identification and molecular characterization of selected LAB isolate 1I1, based on its potent
antimicrobial efficacy, was accomplished using API kit and 16S rRNA gene sequencing analysis. Further, 1I1 was
assessed for α-glucosidase and tyrosinase inhibitory potential as well as antiviral efficacy against highly pathogenic
human influenza virus H1N1 using MDCK cell line in terms of its pharmacological potential.
Results: Here, we first time report isolation as well as biochemical and molecular characterization of a lactic acid
bacterium Lactobacillus sakei 1I1 isolated from the intestine of a fresh water fish Z. koreanus. As a result, L. sakei
1I1 exhibited potent antimicrobial effect in vitro, and diameter of zones of inhibition of 1I1 against the tested
pathogens was found in the range of 13.32 ± 0.51 to 23.16 ± 0.32 mm. Also L. sakei 1I1 at 100 mg/ml exhibited
significant (p < 0.05) α–glucosidase and tyrosinase inhibitory activities by 60.69 and 72.59 %, in terms of
its anti-diabetic and anti-melanogenic potential, respectively. Moreover, L. sakei 1I1 displayed profound
anti-cytopathic effect on MDCK cell line when treated with its ethanol extract (100 mg/ml), confirming its
potent anti-viral efficacy against H1N1 influenza virus.
Conclusions: These findings reinforce the suggestions that L. sakei 1I1 isolated from the intestine of fresh water fish Z.
koreanus might be a candidate of choice for using in pharmacological preparations as an effective drug.
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Background
Microflora of the intestinal tract is an integral part of
the whole living organism. A huge number of endogen-
ous and exogenous factors influence determination of
composition of microbe populations and affect physio-
logical and biochemical features of the microorganisms.
Lactic acid bacteria (LAB) are widely distributed in the
intestinal tract of various animals [1], and some of them
have played an important role in beneficial functions for
industrial animals as probiotics [2]. There have been sev-
eral reports on LAB occurring among the major micro-
bial populations in animal intestine [2, 3]. It is well
established that some LAB improve the intestinal micro-
flora and promote the growth and health of animals [2].
LAB are characterized as Gram-positive, usually non-
motile, non-sporulating bacteria that produce lactic acid
as a major or sole product of fermentative metabolism
which have been classified based on their morphology,
physiology and molecular characteristics [4]. Although
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LAB from food and their current taxonomical status
have been reviewed previously [5], taxonomic studies on
LAB from animal origin are rare [5]. Moreover, LAB
exhibit various medicinal and pharmacological proper-
ties against number of microorganisms, including
food spoilage and pathogenic bacteria as well as var-
iety of viruses [6].
Consequences of diabetes mellitus type 2 stage are as-
sociated with postprandial hyperglycemia due to imbal-
anced acute secretion of insulin after food intake [7].
Digestive enzymes such as glucosidases are well-known
for their ability to break down the larger carbohydrate
molecules into simple monosaccharide molecules. Ex-
cess production of monosaccharide and less uptake of
sugars by the body may result in the development of dia-
betic complications. Inhibitors of glucosidase enzymes
have potent ability to delay the absorption of carbohy-
drates and reduce the digestion rate of carbohydrates
into simple monosaccharides. These features of glucosi-
dase inhibitors allow them to act as anti-diabetic
substances because they reduce postprandial blood
glucose level thereby preventing the incidences of
type-2 diabetes [8].
Tyrosinase, a copper-containing polyphenol oxidase,
plays a highly critical role in forming melanin pigments
[9]. Previous reports have shown that tyrosinase might
also be involved in neuromelanin production and be as-
sociated with Parkinson’s disease [10]. Therefore, inhibit-
ing tyrosinase activity is applicable to skin-lightening
and in preventing neurodegeneration [11]. Although a
broad spectrum of tyrosinase inhibitors are available
[12], there is a still need to explore the microbial world
for inventing more effective classes of tyrosinase inhibi-
tors from LAB due to their Generally Recognized as Safe
“GRAS” status.
Influenza A (H1N1) is the sub-type of influenza A
virus that is known as the most common cause of hu-
man influenza. Consequences of influenza viruses result
in the development of a contagious respiratory disease
influenza, also called flu. It has been confirmed that
every year over 220,000 hospitalizations and approxi-
mately 36,000 annual deaths are reported by influenza
viruses in the USA [13]. Current scenario on emergence
of life threatening viruses has resulted in enormous at-
tention on finding anti-viral drugs of natural origin due
to less potential of currently available anti-viral vaccines
[14], in addition to their limited applications [15] against
influenza viruses. This has resulted in the increasing
need on the development of un-conventional measure-
ments against influenza viruses.
A number of reports have confirmed that LAB are
normal flora in gastrointestinal tract of healthy animals
like mammals and aquaculture animals including fish
[16] with no harmful effects [17]. Probiotics improve
intestinal microflora with health beneficial efficacy pro-
tecting them against infections by stimulating the im-
mune system, as well as alleviate lactose intolerance,
reduce blood cholesterol levels, improve weight gain and
feed conversion ratio [18–21]. Isolation of LAB from
variety of samples has raised debate over the safety of
probiotic bacteria and whether or not the bacteria are
actually infectious [22]. Fish viscera are not only rich in
different biomolecules but are also rich in beneficial
LAB with probiotics properties [23]. Since LAB are
reported to be very effective in recovery of biomole-
cules from fish industry waste [24–26], isolation of
LAB from fish industry waste itself becomes all the
more important.
Against this background, the main objective of present
study was to isolate, and characterize a native LAB strain
L. sakei 1I1 from intestinal microbiota of fresh water fish
Zacco koreanus, and to confirm its various pharmaco-
logical properties such as antimicrobial, α-glucosidase
inhibitory effect, tyrosinase inhibitory effect and antiviral
properties against influenza virus H1N1 in terms of its
bio-preservative, anti-diabetic, anti-melonogenic and
anti-viral potential in order to explore LAB for simul-




The Bromocresol Purple (BCP) agar medium was pur-
chased from Sigma-Aldrich (Sigma, MO, USA). The de
Man, Rogosa and Sharpe (MRS) agar medium was
purchased from Difco (USA). Kojic acid, acarbose,
yeast α-glucosidase, p-nitrophenyl-α-D-glucopyrano-
side, mushroom tyrosinase, and 3,4-dihydroxy-L-
phenylalanine (DOPA) were obtained from Sigma
(MO, USA). Other chemicals and reagents used were
of very pure and high analytical grade.
Microbial strains
The following microorganisms as pathogenic bacteria
were used in this study for preliminary screening includ-
ing Staphylococcus aureus (KCTC 1621), Escherichia coli
O157:H7, Salmonella enterica ATCC 4731, Bacillus sub-
tilis KCTC 1021, and Listeria monocytogenes KCTC
3569. The bacterial pathogens were obtained from the
American Type Culture Collection and Korean Type
Culture Collection, respectively and maintained on nu-
trient agar (NA) medium at 4 °C.
Collection and sampling of fish samples
A total of 64 fresh water fish samples, belonging to dif-
ferent species were collected from five different rivers
and different locations in Korea, supplied by Daejeon
National Science Museum, Daejeon. Fish sampling was
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conducted in the five major river watersheds of Korea
(34–42°N, 124–130°E): the Han River, the Nakdong river,
the Geum river, the Yeongsan river, and the Sumjin river
watersheds during the year 2014. In total, 16 sites con-
sisting of first- through fourth-order streams [27] were
sampled for the five major river watersheds; 3 sites in
the Han river, 4 sites in the Nakdong river, 3 sites in the
Geum river, 3 sites in the Yeongsan river and 3 sites in
the Sumjin river. The sampling approach was followed
by a modified protocol of the Ohio environmental pro-
tection agency (EPA) method [28]. Sampling gears used
were casting nets (mesh size, 7 × 7 mm; 1.5 m × 1.5 m ×
3.14 m) and kick nets (mesh size, 4 × 4 mm, 1.8 m ×
0.9 m), the most common sampling gears used for wad-
ing streams. Casting net was applied to habitats with un-
obstructed open water, viz. riffles, pools, and slow runs,
and kick net was used in sites subject to fast current re-
gime and with obstructions, where it is difficult to use a
casting net. All sampling procedures and/or experimen-
tal manipulations were reviewed following catch per unit
effort (CPUE) methods [29], and the collected samples
were transported in ice-packed boxes to the Microbiome
laboratory, Yeungnam University and stored at −20 °C
for further analysis. In addition, this study did not in-
volve any endangered or protected species, hence no
specific permissions and ethics were required to collect
the fish samples. However, national ethical approval was
obtained for fish samples on “Animal Care and Use” by
the ethical committee of Daejeon National Science Mu-
seum, Daejeon, Korea. All fish samples were of different
feeding nature such as insectivore, omnivore, herbivore,
and carnivore. Taxonomic identification of the fish spe-
cies was conducted by the fish expert at the National
Science Museum of Korea according to the methods of
species identification [30]. A detailed description on var-
iety of fish samples has been given in Table 1.
Isolation, sub-culturing and maintenance of LAB from fish
samples
For isolation of lactic acid bacteria (LAB) from fresh
water fish samples, a previously developed standard ser-
ial dilution method was adopted [31]. In brief, scarifica-
tion of experimental fish was done in a sterilized clean
bench using sterilized knife and forces. To isolate LAB
from fresh water fish samples, dissected fish tissues such
as stomach, gill and intestine were used since these are
known major reservoirs of microbial community in fish.
Each fish sample was dissected, and stomach, gill and in-
testine were collected separately. Each part was weighed
and homogenized using a pestle-mortar followed by ser-
ial dilution in phosphate buffer saline (PBS) using Bro-
mocresol Purple (BCP) agar medium. Each homogenized
sample was put in 1 ml of PBS and vortexed vigorously
in order to make a uniform inoculum size followed by
its serial dilution to the maximum serial dilution factor
from 10−1 to 10−9. Finally an inoculum of 100 μl was
spread on BCP agar plates, and plates were sealed using
paraffin and incubated at 37 °C for 24 h. Identification
of LAB isolates was based on the clear zone around the
colony on BCP agar plates [21]. Each set was prepared
in triplicate and positive results were confirmed. Repre-
sentative colonies were picked from plates and well-
isolated colonies were inoculated into fresh MRS broth
for stock preparation. For long term storage, stock cul-
tures were maintained at −20 °C in MRS broth. A detail
of number of LAB strains isolated from variety of fish
samples has been summarized in Table 2.
Screening of LAB strains on the basis of anti-pathogenic
assay
To confirm the bio-preservative and pharmacological
potential of LAB strains isolated from variety of fresh
water fish samples, anti-pathogenic assay was performed
in vitro using different pathogenic microorganisms in-
cluding Staphylococcus aureus KCTC 1621, Escherichia
coli O157:H7, Salmonella enterica ATCC 4731, Bacillus
subtilis KCTC 1021, and Listeria monocytogenes KCTC
3569. The agar well diffusion method [32] was used for
anti-pathogenic assay. Petri plates were prepared by pour-
ing 20 ml of nutrient broth (NB) medium (BD Difco™) and
allowed to solidify. Plates were dried, and a 24 h grown
culture (200 μl) of each test organism of standardized in-
oculum suspension (107 CFU/ml) was poured and uni-
formly spread, and the inoculum was allowed to dry for
5 min. The wells were made by using sterilized borer
where 100 μl cell free supernatant of isolated LAB strains
was poured in each well against each of the tested patho-
gen. Negative controls were prepared using the same solv-
ent employed to dissolve the samples. Antibacterial
activity was evaluated by measuring the diameter of inhib-
ition zones against the tested bacteria. Each assay in this
experiment was replicated three times.
Morphological and biochemical identification of LAB
isolate
Morphological identification of one of the selected isolates
1I1, based on its potential efficacy in anti-pathogenic
assay, was conducted by observing colony shape on BCP
agar plates, Gram-staining, and cell morphology using
microscope. Selected isolate was biochemically identified
using API 50CH strips with API 50CHL medium at spe-
cies level based on the instructions of manufacturer (API
50 CHL, BioMerieux, France). In brief, freshly-grown bac-
terial colony of the selected LAB isolate was picked-up
and inoculated in MRS medium at 36 °C for 24 h, and
then the bacterial culture was serially diluted to prepare
desired concentration of 108 CFU/ml [33]. From this, ali-
quot (2 ml) was inoculated into APL 50 CHL medium
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(10 ml), and mixed by gentle inversion. Then, a bacterial
suspension (120 μl) was inoculated into API 50 CH strips
that were pre-overlaid with mineral oil followed by further
incubation for 48 h before measuring the color change
abilities. Finally, strips were processed for analyzing the
API profiles using computer APILAB Plus Version.
Molecular characterization of LAB isolate
Molecular methods are important for bacterial identifi-
cation [34], and possibly more accurate for LAB than
conventional phenotypic methods. In this study, LAB
isolate 1I1 showing profound antimicrobial efficacy
against pathogenic bacteria was characterized by 16S
rRNA gene sequencing analysis. The gene sequences
were compared in the National Center for Biotechnology
Information (NCBI) for homology using BLAST and
multiple-aligned with 16S rRNA gene sequences of dif-
ferent strains for similarity using ClustalW program
coupled with MEGA 5. A neighbor-joining method was
employed to construct the phylogenic tree using MEGA
5 software.
Table 1 Isolation of lactic acid bacteria (LAB) from fresh water
fish sample collected from different locations in Korea
Fish samples Number of LAB isolates
Stomach Intestine Gill
Tridentiger bifasciatus – – –
Acanthogobius flavimanus – – 1
Tribolodon hakonensis 3 – –
Pseudobagrus koreanus – – –
Coreoleuciscus splendidus 13 – –
Plecoglossus altivelis – 1 3
Misgurnus anguillicaudatus 1 4 –
Carassius auratus 1 1 –
Pseudorasbora parva – – –
Zacco platypus 1 5 3
Rhinogobius giurinus – – –
Zacco koreanus – – –
Zacco temminckii – – 1
Tridentiger obscurus 2 – –
Zacco koreanus 1 2 3
Odontobutis platycephala 2 2 1
Rhynchocypris oxycephalus 3 1 1
Zacco koreanus 1 3 2
Zacco temminckii 2 2 2
Rhynchocypris oxycephalus 3 3 2
Squalidus gracilis 5 5 2
Microphysogobio yaluensis 4 3 1
Hemibarbus longirostris 2 4 2
Zacco platypus 2 – 2
Odontobutis interrupta 1 2 2
Rhinogobius brunneus 1 1 1
Pseudogobio esocinus 2 – 1
Opsariichthys uncirostris 2 1 1
Zacco koreanus 3 3 4
Rhynchocypris oxycephalus 1 1 1
Odontobutis platycephala 1 1 1
Pungtungia herzi 1 1 2
Zacco platypus 2 2 2
Odontobutis platycephala 3 5 2
Zacco koreanus 3 3 2
Carassius cuvieri 2 2 2
Carassius auratus 3 2 3
Micropterus salmoides 2 3 2
Hemibarbus longirostris 1 1 2
Lepomis macrochirus 3 2 2
Pseudogobio esocinus 3 1 2
Zacco platypus 2 1 2
Table 1 Isolation of lactic acid bacteria (LAB) from fresh water
fish sample collected from different locations in Korea
(Continued)
Squalidus chankaensis 2 2 2
Rhynchocypris oxycephalus 4 1 5
Microphysogobio yaluensis 3 2 2
Rhinogobius brunneus 3 2 2
Zacco temminckii – 3 3
Odontobutis platycephala 2 2 2
Misgurnus anguillicaudatus 2 3 –
Zacco koreanus 2 3 4
Hemibarbus labeo
Pungtungia herzi 2 3 2
Zacco platypus 3 2 1
Microphysogobio yaluensis 3 2 1
Odontobutis platycephala 3 1 1
Pseudogobio esocinus 1 3 2
Squalidus gracilis 4 – 2
Zacco temminckii
Microphysogobio yaluensis 1 – 3
Squalidus gracilis
Pungtungia herzi
Zacco platypus – 2 1
Pseudogobio esocinus – – 3
Odontobutis platycephala – – –
Total 117 99 96
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Pharmacological evaluation of L. sakei 1I1
Extraction and sample preparation
Selection of an accurate methodology is highly recom-
mended for better metabolite extraction and high
amount of yield recovery. Selective use of solvents has
always been recommended for the extraction of specific
category of metabolites such as polar and/or non-polar
or less polar substances based on the solubility of com-
pounds. Since ethanol can significantly extract majority
of biologically active secondary metabolites from variety
of microbial (outer and inner environment of bacterial
cell) extract samples [35], in this study, ethanol solvent
system was selected for extraction purposes. Briefly, to
obtain ethanol extract, L. sakei 1I1 was grown in MRS
broth for 36 h at 37 °C, and then double volume of etha-
nol was added to the culture broth followed by shaking
for 4 h to kill the culture. After that, mixture was centri-
fuged at 8,000 rpm for 20 min. The upper solution
containing ethanol extract was collected, vacuum evapo-
rated and freeze-dried. The yield of ethanol extract of
LAB strain L. sakei 1I1 was found as 19.34 %. Different
test concentrations of freeze-dried ethanol extract of 1I1
were prepared in triple-distilled sterilized water.
Determination of α-glucosidase inhibitory activity
It is not known whether LAB colonizing the human gut
possess inhibitory potential against digestive enzymes
glucosidases. Hence, this study was undertaken to
evaluate α-glucosidase inhibitory potential of 1I1 in
order to confirm its type II anti-diabetic efficacy ac-
cording to the chromogenic method with minor modi-
fications as described previously [36]. Briefly, 50 μl of
various concentrations (100, 50, 25, 5 and 1 mg/ml) of
1I1 ethanol extract and 100 μl of α-glucosidase dis-
solved in 0.1 M phosphate buffer (pH 6.9), were mixed
in a 96-well microplate and incubated at 25 °C for
10 min. After pre-incubation, 50 μl of p-nitrophenyl-α-
D-glucopyranoside (5 mM) in the same buffer (pH 6.9)
as a substrate solution was added to each well. The
reaction mixture was incubated at 25 °C for 5 min.
Absorbance was recorded using a microplate reader
(Tecan, Infinite M200, Mannedorf, Switzerland) at
405 nm before and after incubation with p-nitrophenyl-
α-D-glucopyranoside solution and compared to that of
control, having 50 μl of buffer solution instead of test
solution. Acarbose at various concentrations (0.3125,
0.625, 1.25, 2.5 and 5 μg/ml) was used as a standard
drug. Experiments were performed in triplicate, and en-
zyme inhibitory effect of the samples was calculated by
the formula:
Determination of tyrosinase inhibitory activity
Tyrosinase inhibitory activity of ethanol extract of L.
sakei 1I1 was measured based on the method reported
by Fawole et al. [37] with slight modifications. Briefly,
100 μl of different concentrations (100, 50, 25, 5 and
1 mg/ml) of 1I1 ethanol extract were mixed with
0.175 M sodium phosphate buffer (600 μl) (pH 6.8).
After that, 200 μl of L-DOPA solution (10 mM) was
added to each well, followed by addition of 200 μl of
tyrosinase (110 units/ml in 0.175 M sodium phos-
phate buffer) into the reaction mixture, and incubated
at 37 °C for 2 min. Further, the amount of dopa-
chrome produced in the reaction mixture was mea-
sured at 475 nm using an ELISA reader. Kojic acid
(15.63, 31.25, 62.5, 125 and 250 μg/ml) was used as a
positive control. All the steps in the assay were con-
ducted at room temperature. Experiments were per-
formed in triplicate, and enzyme inhibitory effect of
the samples was calculated as follows:
Table 2 Biochemical characterization of Lactobacillus sakei (1I1)
based on carbohydrate interpretation using API 50 CHL kit
Active ingredient Result Active ingredient Result
Glycerol – Salicin +
Erythritol – D-cellobiose +
D-arabinose – D-maltose +
L-arabinose + D-lactose (bovine origin) +
D-ribose + D-melibiose +
D-xylose + D-saccharose +
L-xylose – D-trehalose +
D-adonitol – Inulin –
Methyl-β-D-xylopyranoside – D-melezitose +
D-galactose + D-raffinose –
D-glucose + Amidon (starch) –
D-fructose + Glycogen –
D-mannose + Xylitol –
L-sorbose – Gentiobiose +
L-rhamnose + D-turanose +
Dulcitol – D-lyxose –
Inositol – D-tagatose +
D-mannitol + D-fucose –
D-sorbitol + L-fucose –
Methyl-α-D-glucopyranoside – D-arabitol –
N-acetylglucosamine + Potassium gluconate +
Amygdalin + Potassium 2-ketogluconate –
Arbutin + Potassium 5-ketogluconate –
Esculin –
(−): The bacterium does not use this carbohydrate; (+): The bacterium uses
this carbohydrate
Inhibition %ð Þ ¼ ðControl absorbance−Sample absorbance=
Control absorbanceÞ  100
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Inhibition %ð Þ ¼ Control absorption−Sample absorptionð Þ=
Control absorption 100
Determination of antiviral effect
Harvesting of H1N1 virus from embryonated egg
A pathogenic H1N1 influenza virus (A/ Korea/01/2009)
was procured from Korea Centers for Disease Control
and Prevention, South Korea. Propagation of influenza
virus (H1N1) was maintained on MDCK cell-line for
72 h at 37 °C, in a carbon dioxide (4 %) environment,
and allantoic fluid was stored at −80 °C before use. Har-
vesting of virus H1N1 was accomplished from infected
MDCK cell by centrifugation (1,500 rpm) for 5 min. The
H1N1 titer was determined as 106.5 median embryo in-
fection dose (EID50)/0.1 ml as reported by Rather et al.
and Reed and Muench [6, 38].
Assay test against H1N1 virus on MDCK cells
MDCK cell-line was cultured and maintained on DMEM
medium with 10 % (v/v) fetal bovine serum (FBS), 1 % (v/
v) penicillin (100 U/mol), and streptomycin (100 μg/ml)
solution. After filter sterilization, ethanol extract (200 ~
12.5 mg/ml) of L. sakei 1I1 was serially diluted in DMEM
solution with FBS (2 %, v/v), 1 % (v/v) penicillin (100 U/
mol), and streptomycin (100 μg/ml) solution. The H1N1
influenza virus was treated with a two-fold dilution of test
sample of 1I1 in sterilized distilled water at 37 °C, under
5 % carbon dioxide for 1 h. Further, this reaction mixture
was injected into MDCK cell-line, followed by incubation
in DMEM solution with FBS (2 %, v/v) at 37 °C in a
humidified chamber under 5 % carbon dioxide for 48 h.
Confirmation of antiviral activity was made by observing
the plates after 72 h for cytopathic effect (CPE). No CPE
confirmed the presence of antiviral activity [6, 39].
Statistical analysis
Each experiment was performed in triplicate to calculate
mean ± SD, and data were analyzed using one-way
ANOVA to find statistical significance at p < 0.05.
Results and discussion
Isolation of LAB strains from fish samples
As presented in Table 1, a total of 312 LAB strains were
isolated on BCP media from different tissues samples
such as stomach, intestine and gills of 54 fresh water fish
samples. Among three samples utilized for isolation of
LAB isolates, stomach tissue showed higher number of
LAB isolates (116) followed by intestine (99) and gills
(96). Interestingly, 13 LAB strains were isolated from
stomach tissue of one of the fish samples Coreoleuciscus
splendidus. Surprisingly, no LAB strain was isolated
from any fish tissue samples (stomach, intestine and gill)
of Tridentiger bifasciatus, Pseudobagrus koreanus, Pseu-
dorasbora parva, Rhinogobius giurinus, Zacco koreanus,
Hemibarbus labeo, Zacco temminckii, Squalidus gracilis,
Pungtungia herzi and Odontobutis platycephala. In this
study, a higher number of LAB were isolated from stom-
ach tissue sample of a fresh water fish Coreoleuciscus
splendidus. Also one of the fish samples Zacco platypus
possessed higher number of LAB isolates in its stomach,
intestine and gill microbiota as compared to other fish
samples (Table 1).
Nair et al. [40] also reported distribution of different
genera of LAB in fresh and frozen fish and prawn. They
observed that from the cultures, 60 in fresh fish, 65 in
fresh prawn and 80 % each in frozen fish and prawn
belonged to the Lactobacillus genus. It is interesting to
note that majority of the Lactobacillus spp. that have
been isolated from fresh and frozen fish/prawns were
those species which were commonly found on meat, ani-
mals and humans [41].
Anti-pathogenic potential of L. sakei 1I1
All the LAB strains isolated from various parts (stomach,
intestine and gill) of fresh water fish samples were named
accordingly coded with initial character of their respective
tissue origin. Further, each LAB isolate was grown in MRS
medium at 37 °C for 24 h. The culture was centrifuged at
12,000 rpm for 15 min to obtain cell free supernatant
(CFS). Filter sterilize supernatant was further subjected to
evaluate antimicrobial efficacy against pathogenic micro-
organisms using agar well diffusion assay. In each in-
stance, diameter of inhibition zone was quantified against
each bacterial species, and some of the tested strains of
LAB showed remarkable antimicrobial activity against the
tested pathogenic bacteria (data not shown). It was found
in this study that the LAB isolated from the gill and intes-
tine samples exhibited higher anti-pathogenic effect com-
pared to LAB strains isolated from stomach samples. The
findings of this study confirmed that the LAB strains iso-
lated from the fresh water fish samples have potent thera-
peutic and biological potential to develop natural and
novel types of antibiotics to combat against pathogenic
microorganism causing severe diseases in humans and an-
imals. Based on the result of aforementioned test, one of
the strains Lactobacilli sakei 1I1, isolated from fresh water
fish Zacco koreanus, showing highest antimicrobial activ-
ity against the tested pathogens (Fig. 1) was chosen as an
active LAB isolate and was subjected to biochemical and
molecular identification. Further, L. sakei 1I1 was assessed
for its various pharmacological activities including anti-
diabetic, anti-melanogenic and anti-viral efficacy.
Morphological and biochemical identification
Morphological identification of LAB isolate 1I1 was car-
ried out as per the schemes outlined in the Bergey’s
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manual of Systematic Bacteriology [42]. Small yellow col-
onies of similar sizes that appeared on BCP agar using
pour-plating method confirmed the presence of Lactoba-
cillus strain as also reported previously [43]. The efficiency
of detection of other Bifidobacterium such as B. infantis
on BCP was very low, while B. bifidum did not grow on
BCP even under anaerobic conditions [43]. Although plate
count agar with Bromocresol Purple is a recommended
medium for enumeration of LAB from variety of samples,
it does not support the differentiation of each LAB in a
mixed culture. It is known that BCP agar also prevents
formation of colonies by concomitant bacteria and hence
widely considered specific medium for the selective enu-
meration of LAB as also reported by others [44].
Further, biochemical analysis of 1I1 was done by using
API50 strip kit and selected strain was identified as a
Gram-positive and rod-shaped isolate which was found
most closely associated to L. sakei (Table 2). The API
web software confirmed that strain 1I1 showed typical
utilization of carbohydrates that included L-arabinose,
D-ribose, D-xylose, D-galactose, D-glucose, D-fructose,
D-mannose, L-rhamnose, D-mannitol, D-sorbitol, N-
acetylglucosamine, amygdalin, arbutin, salicin, D-cellobiose,
D-maltose, D-lactose, D-melibiose, D-saccharose, D-
trehalose, D-melezitose, gentiobiose, D-turanose, D-
tagatose, and potassium gluconate (Table 2). Color
change from violet to yellow in the strip capsule indicated
complete fermentation of 1I1. Recently Casaburi et al.
[45] also phenotypically and biochemically identified
Lactobacillus species with the use of API50 kit isolated
from fermented sausage.
Molecular characterization of L. sakei 1I1
Molecular identification of 1I1 was based on using 16S
rRNA gene sequencing analysis. As a result, on the basis
of molecular analysis with 16S rDNA gene sequencing,
selected strain showed 99.9 % similarity with different L.
sakei spp. (Fig. 2). The sequence was submitted in Gen-
Bank with nucleotide accession number KT372706.
Thus, the strain was finally confirmed as L. sakei 1I1.
Jini et al. [46] also isolated two potential isolates of LAB
such as Enterococcus faecalis and Pediococcus acidilactici
from fresh water fish microbiota having anti-pathogenic
effect against human pathogens. Zapata [21] studied
intestinal microflora of Oreochromis niloticus fish to iso-
late and identify LAB as new probiotics with a possibility
to use them in aquaculture. It is known that the micro-
biota of fish is affected by nutritional, physiological and
environmental factors, and it is also expected that the
microbial population of fish vary among species [47].
Nevertheless, some authors have considered that sea-
sonal change could be a decisive factor [48], indicating
that it is very likely that feeding habits did not have a
significant influence on fish LAB composition, when the
fish species were grown in the same conditions. Consist-
ent with these findings, our results showed that all spe-
cies collected in different months had a different LAB
composition, represented by various number and variety
of LAB species.
α-Glucosidase inhibitory activity
In this study, anti-diabetic efficacy of L. sakei 1I1 was
confirmed in α-glucosidase inhibition assay. The α-
glucosidase inhibitory activity of ethanol extract of 1I1
was determined using p-nitrophenyl-α-D-glucopyrano-
side (pNPG) as a substrate and compared with standard
compound acarbose. Higher blood glucose levels result
in the development of a chronic metabolic disorder
called diabetes mellitus. Prevention and control of after-
meal blood glucose levels are considered preventive
Fig. 1 Diameters of inhibition zones of cell free supernatant of L. sakei 1I1 against test pathogens in anti-pathogenic assay. Data are expressed as
mean ± SD (n = 3). Values with different superscripts are significantly different (p < 0.05)
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measures to treat diabetes at early stage which may re-
sult in the reduction of carbohydrate absorption from
food by the inhibitory effect of α-glucosidase-like digest-
ive enzymes [49]. Though commercial drugs as inhibi-
tors of α-glucosidase enzymes are available, an approach
on the development of new types of effective alternative
measures is needed for inhibiting the action of these di-
gestive enzymes to meet drug cost potential and to reduce
the adversary side effects of chemical-based enzyme inhib-
itors. Moreover, glucosidases may play an active role in
the carbohydrate metabolism of beneficial and pathogenic
LAB species. Glucosidase activity is widespread among
LAB and β-glucosidases release a wide range of plant sec-
ondary metabolites from their β-D-glucosylated precur-
sors [50]. Plant metabolite deglycosylation has been
shown to improve the flavour or fragrance of fermented
products. It also increases the bioavailability of health-
promoting, antioxidative plant metabolites [50]. For
instance, soybeans contain high concentrations of β-
glucosides genistin and daidzin which are hydrolyzed by
β-glucosidase activities of LAB during soy milk fermenta-
tions. Fermentations with LAB could also increase the
concentrations of bioactive isoflavones in traditional
oriental herbal medicine formulas [50]. Cassava contains
high concentrations of toxic cyanogenic glucoside lina-
marin, and LAB contribute to linamarin degradation by β-
glucosidase activities [50]. In addition, there is consider-
able interest in the α- and β-glucosidase activities of LAB
that conduct the malolactic fermentation of wine. The
main volatile constituents of the primary wine aroma are
terpenoid compounds derived from the grapes. As
these can be released from glycosylated precursors, β-
glucosidase activities of malolactic bacteria are of interest
due to their impact on the aroma profile of wines [50].
The α-glucosidase inhibitory activity of ethanol extract
of 1I1 was found to be in a concentration-dependent
manner (Fig. 3a). The ethanol extract of 1I1 at different
concentrations of 1, 5, 25, 50 and 100 mg/ml showed
the inhibition of α-glucosidase by 9.34, 12.53, 21.54,
36.32 and 60.69 %, respectively (Fig. 3a). On the other
hand, acarbose as a standard drug at various concentra-
tions (0.3125, 0.625, 1.25, 2.5 and 5 μg/ml) displayed α-
glucosidase inhibitory activities by 31.84, 42.07, 54.99,
68.59, and 80.32 %, respectively which were also found
in a concentration-dependent manner (Fig. 3b).
Similarly, Ramchandran and Shah [51] reported α-
glucosidase inhibitory activity of some selected LAB
strains, isolated from yogurt starter culture and it was
found that all selected strains such as L. casei, L. acidoph-
ilus, L. delbrueckii ssp. bulgaricus, and Bifidobacterium
longum exhibited considerable amount of α-glucosidase
inhibitory activity, being very high (>80 %). Recently Pan-
war et al. [52] also reported that LAB strains present in
the human gut showed α- and β-glucosidase inhibitory ac-
tivities as well as reduced blood glucose responses in vivo.
Lastly, the inhibitory activity of whole culture ethanol ex-
tract of 1I1 observed was clearly in a concentration-
dependent, indicating that intracellular cytoplasmic con-
tents or products of bacterial metabolism may be respon-
sible for this activity. Yet this LAB strain, isolated from
fish microbiota has not been studied, and it appears that
this organism may have some anti-diabetic properties
along with its probiotic nature.
Tyrosinase inhibitory activity
Melanin is a color-determinant naturally found in ani-
mals, plants, and microorganisms. Production of various
types of melanins is a process of number of enzymatic
Fig. 2 Neighbor-joining phylogenetic tree showing the position of strain L. sakei 1I1 among the different Lactobacillus strains based on 16 s
rDNA sequences
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and non-enzymatic oxidation steps and polymerization re-
actions. Due to its color reaction and solubility in alkaline
medium, it can be divided in two sub-categories eumelanin
and pheomelanin [53]. Mechanism of tyrosinase inhibition
could be an important factor in the skin whitening and in-
hibition of browning reaction [53]. During melanin biosyn-
thesis, L-DOPA substrate converts into L-dopaquinone
through various enzymatic oxidation processes resulting in
the formation of polymerized melanin [53].
The inhibitory effect of L. sakei 1I1 ethanol extract on
the tyrosinase using a mushroom tyrosinase is demon-
strated in Fig. 4. In this assay, ethanol extract of 1I1 (1,
5, 25, 50 and 100 mg/ml) showed inhibition of tyrosinase
by 9.36, 15.33, 22.44, 39.34 and 72.59 %, respectively
(Fig. 4a). Whereas, mushroom tyrosinase inhibitory ef-
fect of kojic acid (15.63, 31.25, 62.5, 125 and 250 μg/ml)
was found to be 76.60, 85.52, 91.17, 93.94 and 95.90 %,
respectively (Fig. 4b). Kim et al. [54] reported that
ethanolic extract of Cortex radicis bio-transformed by
Leuconostoc paramesenteroides PR effectively enhanced
the tyrosinase inhibitory activity by 6.5-fold in in vitro.
Also Usuki et al. [55] demonstrated that LAB and/or
their derivatives have wide range of application in the
development of skin-whitening and cosmetic products
with antioxidant potential that could directly inhibit
tyrosinase enzyme activity. Herein this study, ethanol
extract of 1I1 also exerted dose-dependent tyrosinase
activity. It has been found that inhibitors of tyrosinase
play a crucial role to maintain the imbalance of melanin
biosynthesis through inhibition of conversion of tyrosine
to DOPA, dopaquinone and subsequent formation of
melanin [53].
Fig. 3 α-glucosidase inhibitory effect of ethanol extract of L. sakei 1I1 (a) and standard drug compound acarbose (b). Data are expressed as
mean ± SD (n = 3). Values with different superscripts are significantly different (p < 0.05)
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Antiviral effect against H1N1 influenza virus using
MDCK cells
To further confirm the pharmacological potential of 1I1,
ethanol extract of 1I1 was tested for its potent antiviral
efficacy against H1N1 influenza virus on MDCK cell-
line. It was found that H1N1 when used alone caused
cytopathic effect (CPE) in MDCK cell-line (Fig. 5a).
However, the same CPE was not observed in control
MDCK cells (Fig. 5b). Further observations based on
microscopic analysis confirmed that MDCK cells treated
Fig 4 Tyrosinase inhibitory effect of ethanol extract of L. sakei 1I1 (a) and standard drug compound kojic acid (b). Data are expressed as mean ±
SD (n = 3). Values with different superscripts are significantly different (p < 0.05)
Fig. 5 Visualization of cytopathogenic effects of H1N1 virus infection in MDCK cells. Cytopathogenic effect in MDCK cells treated with H1N1 virus
(a); control MDCK cells without any treatment (b); and anti-cytopathic effect in MDCK cells treated with Lactobacillus sakei 1I1 and H1N1 (c). Pictures
were taken under fluorescence microscope at a magnification of 40×
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with H1N1 and ethanol extract of L. sakei 1I1 (100 mg/
ml) revealed similar morphological pattern as did by the
control MDCK cells (no treatment) even after 72 h of
the viral injection as shown in Fig. 5c. These findings
suggested that 1I1 could be a potential anti-viral candi-
date to control CPE in MDCK cell-line. Recently we also
reported that LAB strain isolated from different sources
such a Korean traditional fermented food “Kimchi” ex-
hibited potent antiviral effect against H1N1 influenza
virus [6]. Tomosada et al. [56] also observed that it is
possible to beneficially modulate the respiratory defense
against respiratory syndrome virus (RSV) by using
immunobiotics from Lactobacillus strains. Oh et al. [57]
observed that oral administration of L. gasseri might
protect a host animal from influenza virus (IFV) infec-
tion. Recently Kiso et al. [58] evaluated prophylactic
efficacy of Lactobacillus pentosus b240 against lethal
influenza A (H1N1) virus infection in a mouse model,
suggesting it to be an effective candidate in anti-viral
therapy.
Conclusions
This study confirmed that LAB isolate L. sakei 1I1, first
time isolated from the intestine of fresh water fish Zacco
koreanus exhibited inhibitory effect on α-glucosidase
and tyrosinase enzymes in terms of its potent anti-
diabetic and anti-melanogenic activities, respectively as
well as exhibited anti-viral effect against influenza virus
H1N1 on MDCK cells. These findings reinforce the sug-
gestion that L. sakei 1I1 having a broader spectrum of
pharmacological activities could be a novel candidate for
using in health-care, food system and/or as dietary drug
therapies in the treatment of various infectious diseases.
Although this study ends with the development of an ef-
fective anti-diabetic, anti-melanogenic and anti-influenza
candidate L. sakei 1I1, in vivo studies using live cultures
of 1I1 in animal models should be undertaken to better
understand the source of bioactivities.
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